Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,566 | 106 | 99.9% |
| Education | $3.82 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $528.60 | 21 | $0 (2024) |
| Boston Scientific Corporation | $433.21 | 10 | $0 (2024) |
| Biocompatibles, Inc. | $206.30 | 14 | $0 (2019) |
| PFIZER INC. | $198.52 | 10 | $0 (2023) |
| Janssen Biotech, Inc. | $164.17 | 5 | $0 (2024) |
| Axonics, Inc. | $110.38 | 5 | $0 (2024) |
| ABBVIE INC. | $106.40 | 6 | $0 (2024) |
| Teleflex LLC | $92.97 | 4 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $85.24 | 4 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $83.36 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $581.99 | 22 | Janssen Biotech, Inc. ($110.85) |
| 2023 | $695.85 | 29 | Astellas Pharma US Inc ($230.32) |
| 2022 | $353.39 | 18 | PFIZER INC. ($118.87) |
| 2021 | $274.08 | 13 | Astellas Pharma US Inc ($137.22) |
| 2020 | $100.93 | 5 | Astellas Pharma US Inc ($63.67) |
| 2019 | $274.03 | 15 | Biocompatibles, Inc. ($192.93) |
| 2018 | $165.94 | 3 | BOSTON SCIENTIFIC CORPORATION ($152.57) |
| 2017 | $123.27 | 2 | BOSTON SCIENTIFIC CORPORATION ($88.49) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 12/05/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $45.47 | General |
| Category: Urology | ||||||
| 10/24/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: UROLOGY | ||||||
| 10/15/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $32.55 | General |
| Category: UROTHELIAL CANCER | ||||||
| 08/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: UROLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/25/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $36.12 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: ONCOLOGY | ||||||
| 06/25/2024 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Oncology | ||||||
| 04/27/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/24/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $64.85 | General |
| Category: Oncology | ||||||
| 04/18/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Urology | ||||||
| 03/22/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Urology | ||||||
| 03/05/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/21/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: Urology | ||||||
| 01/30/2024 | Axonics, Inc. | Bulkamid (Device), Axonics | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Urology | ||||||
| 12/20/2023 | Boston Scientific Corporation | SpaceOAR System (Device) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Space OAR_URO | ||||||
| 11/29/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/28/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Interventional Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,036 | 16,271 | $568,814 | $157,373 |
| 2022 | 31 | 2,182 | 13,638 | $557,778 | $171,419 |
| 2021 | 30 | 2,200 | 13,701 | $491,982 | $141,839 |
| 2020 | 8 | 435 | 477 | $55,672 | $17,434 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 266 | 407 | $81,011 | $35,526 | 43.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 26 | 165 | $31,230 | $21,920 | 70.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 191 | 253 | $34,408 | $15,433 | 44.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $23,247 | $9,399 | 40.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 161 | 223 | $18,063 | $8,498 | 47.0% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 15 | 15 | $46,620 | $8,370 | 18.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 105 | 126 | $53,802 | $6,960 | 12.9% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 18 | 18 | $26,788 | $5,351 | 20.0% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 19 | 2,250 | $13,500 | $4,978 | 36.9% |
| 76100 | X-ray of body plane | Office | 2023 | 59 | 73 | $20,440 | $4,719 | 23.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 49 | 53 | $19,239 | $4,593 | 23.9% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 24 | 52 | $15,704 | $3,586 | 22.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 250 | 385 | $25,795 | $3,100 | 12.0% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 413 | 756 | $12,852 | $2,930 | 22.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 24 | 29 | $24,354 | $2,857 | 11.7% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 30 | 53 | $16,218 | $2,502 | 15.4% |
| 52442 | Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | Facility | 2023 | 12 | 53 | $14,681 | $1,934 | 13.2% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 15 | 16 | $11,952 | $1,911 | 16.0% |
| 52441 | Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | Facility | 2023 | 13 | 13 | $10,413 | $1,759 | 16.9% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 19 | 19 | $7,505 | $1,668 | 22.2% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 15 | 29 | $7,975 | $1,646 | 20.6% |
| 55874 | Injection of biodegradable material next to prostate | Office | 2023 | 14 | 14 | $8,246 | $1,420 | 17.2% |
| 51705 | Simple change of bladder tube | Office | 2023 | 14 | 21 | $6,972 | $1,212 | 17.4% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 17 | 17 | $5,304 | $1,123 | 21.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,842 | $853.78 | 30.0% |
About Christopher Meier
Christopher Meier is a Urology healthcare provider based in Iowa City, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2012. The National Provider Identifier (NPI) number assigned to this provider is 1699033258.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Meier has received a total of $2,569 in payments from pharmaceutical and medical device companies, with $581.99 received in 2024. These payments were reported across 107 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,566).
As a Medicare-enrolled provider, Meier has provided services to 6,853 Medicare beneficiaries, totaling 44,087 services with total Medicare billing of $488,065. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Iowa City, IA
- Active Since 05/01/2012
- Last Updated 08/21/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1699033258
Products in Payments
- XTANDI (Drug) $399.41
- AMS (Device) $322.16
- Myrbetriq (Drug) $305.23
- THERASPHERE-BIO (Device) $206.30
- ERLEADA (Drug) $164.17
- LUPRON DEPOT (Drug) $106.40
- SpaceOAR VUE System - 10mL (Device) $93.68
- GEMTESA (Drug) $85.24
- Bulkamid (Device) $83.73
- ADSTILADRIN (Biological) $83.36
- UROLIFT (Device) $62.40
- JELMYTO (Drug) $59.98
- PYLARIFY (Drug) $52.30
- AVEED (Biological) $52.09
- Titan (Device) $49.31
- EKOSONIC (Device) $34.78
- KEYTRUDA (Biological) $31.51
- UroLift System (Device) $30.57
- Da Vinci Surgical System (Device) $26.87
- Axonics (Device) $26.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Iowa City
Dr. Michael Odonnell, Md, MD
Urology — Payments: $79,346
Katherine Cotter, Md, MD
Urology — Payments: $75,684
Bradley Erickson, M.d, M.D
Urology — Payments: $63,949
Alexandria Hertz
Urology — Payments: $50,787
Dr. Vignesh Packiam, M.d, M.D
Urology — Payments: $39,299
Dr. Hing Hung Lai, Md, MD
Urology — Payments: $22,467